BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 16925290)

  • 1. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
    Swartz DE; Felix EL
    Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
    Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
    Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass.
    Papasavas PK; Gagné DJ; Ceppa FA; Caushaj PF
    Surg Obes Relat Dis; 2006; 2(1):41-6; discussion 46-7. PubMed ID: 16925315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary.
    Patel KR; White SC; Tejirian T; Han SH; Russell D; Vira D; Liao L; Patel KB; Gracia C; Haigh P; Dutson E; Mehran A
    Am Surg; 2006 Oct; 72(10):857-61. PubMed ID: 17058721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass?
    Taylor J; Leitman IM; Horowitz M
    Obes Surg; 2006 Jun; 16(6):759-61. PubMed ID: 16756738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass.
    Kellogg TA; Andrade R; Maddaus M; Slusarek B; Buchwald H; Ikramuddin S
    Surg Obes Relat Dis; 2007; 3(1):52-7; discussion 58-9. PubMed ID: 17116426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait?
    Hamad GG; Ikramuddin S; Gourash WF; Schauer PR
    Obes Surg; 2003 Feb; 13(1):76-81. PubMed ID: 12630618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallbladder disease in patients undergoing laparoscopic adjustable gastric banding.
    Myers JA; Fischer GA; Sarker S; Shayani V
    Surg Obes Relat Dis; 2005; 1(6):561-3. PubMed ID: 16925291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rational approach to cholelithiasis in bariatric surgery: its application to the laparoscopically placed adjustable gastric band.
    O'Brien PE; Dixon JB
    Arch Surg; 2003 Aug; 138(8):908-12. PubMed ID: 12912752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder management in obesity surgery.
    Mason EE; Renquist KE
    Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective comparison of vertical banded gastroplasty and Roux-en-Y gastric bypass in a non-superobese population.
    Kalfarentzos F; Skroubis G; Kehagias I; Mead N; Vagenas K
    Obes Surg; 2006 Feb; 16(2):151-8. PubMed ID: 16469216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrojejunal anastomotic strictures following laparoscopic Roux-en-Y gastric bypass surgery: analysis of 1291 patients.
    Carrodeguas L; Szomstein S; Zundel N; Lo Menzo E; Rosenthal R
    Surg Obes Relat Dis; 2006; 2(2):92-7. PubMed ID: 16925329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revision of failed laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass.
    van Wageningen B; Berends FJ; Van Ramshorst B; Janssen IF
    Obes Surg; 2006 Feb; 16(2):137-41. PubMed ID: 16469213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients developed symptomatic gallstones between 3 and 21 months after Roux-en-Y gastric bypass (RYGB), neither prophylactic cholecystectomy nor treatment with ursodeoxycholic acid is necessary after open RYGB.
    Sarr MG
    Surg Obes Relat Dis; 2006; 2(2):233; author reply 233. PubMed ID: 16925352
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass.
    Escalante-Tattersfield T; Tucker O; Fajnwaks P; Szomstein S; Rosenthal RJ
    Surg Obes Relat Dis; 2008; 4(2):126-30. PubMed ID: 18359453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine cholecystectomy is not mandatory during morbid obesity surgery.
    Ellner SJ; Myers TT; Piorkowski JR; Mavanur AA; Barba CA
    Surg Obes Relat Dis; 2007; 3(4):456-60. PubMed ID: 17442623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Totally robotic Roux-en-Y gastric bypass.
    Mohr CJ; Nadzam GS; Curet MJ
    Arch Surg; 2005 Aug; 140(8):779-86. PubMed ID: 16103289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease.
    Fobi M; Lee H; Igwe D; Felahy B; James E; Stanczyk M; Fobi N
    Obes Surg; 2002 Jun; 12(3):350-3. PubMed ID: 12082886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lap-Band patients in a single US center with three-year follow-up.
    Cottam DR; Atkinson J; Anderson A; Grace B; Fisher B
    Obes Surg; 2006 May; 16(5):534-40. PubMed ID: 16687018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric restrictive procedures to treat obesity: reasons for failure and long-term evaluation of the results of operative revision.
    Kaminski DL
    Int J Surg Investig; 2001; 2(5):413-21. PubMed ID: 12678546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.